Works matching IS 14741776 AND DT 2013 AND VI 12 AND IP 12
Results: 31
Metabolic targets for cancer therapy.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 963, doi. 10.1038/nrd4191
- By:
- Publication type:
- Article
Target identification: Blocking vasopressin receptors reduces jet lag.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 903, doi. 10.1038/nrd4180
- By:
- Publication type:
- Article
Modulation of oxidative stress as an anticancer strategy.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 931, doi. 10.1038/nrd4002
- By:
- Publication type:
- Article
Chemical predictive modelling to improve compound quality.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Histone lysine demethylases as targets for anticancer therapy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The risks of risk aversion in drug regulation.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The value of single-pathogen antibacterial agents.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 963, doi. 10.1038/nrd3957-c1
- By:
- Publication type:
- Article
Time to rethink dose-finding study design.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 895, doi. 10.1038/nrd4193
- Publication type:
- Article
VC and non-profit unite to launch new companies.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 895, doi. 10.1038/nrd4195
- Publication type:
- Article
Drugging cancer genomes.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 889, doi. 10.1038/nrd4184
- By:
- Publication type:
- Article
Charles Hugh-Jones.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 900, doi. 10.1038/nrd4190
- Publication type:
- Article
Histone lysine demethylases as targets for anticancer therapy.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 917, doi. 10.1038/nrd4154
- By:
- Publication type:
- Article
Chemical predictive modelling to improve compound quality.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 948, doi. 10.1038/nrd4128
- By:
- Publication type:
- Article
Neurodegenerative disease: Tau immunotherapy targets transcellular propagation.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 904, doi. 10.1038/nrd4179
- By:
- Publication type:
- Article
Learning from the 2012-2013 class of breakthrough therapies.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 891, doi. 10.1038/nrd4196
- By:
- Publication type:
- Article
NIH denies march-in rights on Norvir patent.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 898, doi. 10.1038/nrd4198
- By:
- Publication type:
- Article
Autoimmune disease: Parkinson's drug promotes myelin repair.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 905, doi. 10.1038/nrd4181
- By:
- Publication type:
- Article
Neurological disorders: Chloride extrusion alleviates neuropathic pain.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 906, doi. 10.1038/nrd4183
- By:
- Publication type:
- Article
The GHIT fund shows its cards.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 894, doi. 10.1038/nrd4197
- By:
- Publication type:
- Article
Does size matter in R&D productivity? If not, what does?
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 901, doi. 10.1038/nrd4164
- By:
- Publication type:
- Article
With great speed comes great need for post-marketing oversight?
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 895, doi. 10.1038/nrd4194
- Publication type:
- Article
Bone disorders: Targeting NOX4 knocks down osteoporosis.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 904, doi. 10.1038/nrd4182
- By:
- Publication type:
- Article
Market watch: Defining and quantifying the use of personalized medicines.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 896, doi. 10.1038/nrd4177
- By:
- Publication type:
- Article
Trial watch: Phase II boost for glutamate-targeted antidepressants.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 897, doi. 10.1038/nrd4178
- By:
- Publication type:
- Article
Neurodegenerative disease: A PERK for the therapy of prion disease.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 906, doi. 10.1038/nrd4185
- By:
- Publication type:
- Article
Target validation: Tinkering with heart disease.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 906, doi. 10.1038/nrd4186
- By:
- Publication type:
- Article
Computational biology: Structural insights into allosteric GPCR drugs.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 906, doi. 10.1038/nrd4188
- By:
- Publication type:
- Article
The risks of risk aversion in drug regulation.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 907, doi. 10.1038/nrd4129
- By:
- Publication type:
- Article
Neurodegenerative disease: Patient stem cells give clues to ALS.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 906, doi. 10.1038/nrd4187
- By:
- Publication type:
- Article
Recent patents related to histone demethylases.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 899, doi. 10.1038/nrd4199
- By:
- Publication type:
- Article
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 887, doi. 10.1038/nrd4192
- Publication type:
- Article